A Retrospective Review and Comprehensive Tumour Profiling of Advanced Non-Melanomatous Cutaneous Spindle Cell Neoplasms Treated with Immune-Checkpoint Inhibitors
Authors:
- Luke S. McLeanLMLuke S. McLean
- Annette M. LimALAnnette M. Lim
- Christopher AngelCAChristopher Angel
- Richard J. YoungRYRichard J. Young
- Angela PizzollaAPAngela Pizzolla
- Stuart ArcherSAStuart Archer
- Benjamin J. SolomonBSBenjamin J. Solomon
- Alesha A. ThaiATAlesha A. Thai
- Jeremy LewinJLJeremy Lewin
- Danny RischinDRDanny Rischin
Open Access
Abstract
Non-melanomatous cutaneous spindle cell neoplasms are a rare group of malignancies that present a diagnostic challenge, and for which there is a lack of consensus on how to best manage patients with advanced disease and only limited reports of immune-checkpoint inhibitor (ICI) responses. In this study, we performed a single-center retrospective review of treatment outcomes for all advanced non-melanomatous cutaneous spindle cell neoplasms treated with ICIs. Blinded histopathology reviews occurred to confirm each diagnosis. Comprehensive tumour profiling included whole exome sequencing for tumour mutational burden (TMB) and ultraviolet(UV) signatures, and immunohistochemistry for immune-cell infiltration (CD4/CD3/CD8/CD103/CD20) and immune-checkpoint expression (PD-L1/LAG3/TIGIT). Seven patients were identified. The objective response rate was 86% (6/7) with five complete responses (CR). Responses were durable with two patients in CR > 30 months after ICI commencement. All patients had high TMB and UV signatures. One patient had PD-L1 100% (combined positive score) with abundant immune-cell infiltration and LAG3 expression. In advanced non-melanomatous cutaneous spindle cell neoplasms, excellent responses to ICIs with durable disease control were observed. ICIs are worthy of further exploration in these patients. UV signatures and high TMB could be used to help select patients for treatment.Keywords
Funding Information
- National Health and Medical Research Council (APP1175929)
This publication has 49 references indexed in Scilit:
- Atypical fibroxanthoma and pleomorphic dermal sarcoma: Local recurrence and metastasis in a nationwide population-based cohort of 1118 patientsJournal of the American Academy of Dermatology, 2023
- Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemiaAnnals of Oncology, 2023
- Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trialThe Lancet Oncology, 2020
- Genetic Mutations Underlying Phenotypic Plasticity in Basosquamous CarcinomaJournal of Investigative Dermatology, 2019
- Immune-phenotyping of pleomorphic dermal sarcomas suggests this entity as a potential candidate for immunotherapyCancer Immunology, Immunotherapy, 2019
- Complete pathologic response of metastatic cutaneous squamous cell carcinoma and allograft rejection after treatment with combination immune checkpoint blockadeJAAD Case Reports, 2017
- Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancerNature Communications, 2017
- Salmon provides fast and bias-aware quantification of transcript expressionNature Methods, 2017
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Induced expression of PD‐1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.The EMBO Journal, 1992